Advertisement

Hepatic Neoplasms Associated with Contraceptive and Anabolic Steroids

  • Kamal G. Ishak
Chapter
Part of the Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer book series (RECENTCANCER, volume 66)

Abstract

An association between hepatocellular adenoma (HCA) and oral contraceptives (OC) was first pointed out by BAUM et al. in 1973 [12]. Other examples followed as well as reports of possible associations between OC and focal nodular hyperplasia (FNH), hepatocellular carcinoma (HCC), and other malignant hepatic tumors [1, 3–5, 7–10, 17, 20, 21, 23, 24, 26–28, 31, 32, 35, 43, 44, 49, 51–56, 59, 65, 71, 74, 77, 80, 84, 90, 92–95, 100–102, 105, 111, 115, 116, 120, 126, 129, 133, 137, 141, 143–145, 147, 148]. The occurrence of HCC and other tumors of the liver in patients receiving anabolic steroids has been the subject of many reports [18, 22, 48, 57, 61, 64, 72, 73, 78, 86, 99, 103, 108, 119, 121, 127, 128, 139, 155]. Likewise a number of editorials [37–40, 134] and several reviews have dealt with tumors of the liver associated with OC [49, 79, 114, 123, 131].

Keywords

Oral Contraceptive Anabolic Steroid Focal Nodular Hyperplasia Fibrous Septum Nodular Regenerative Hyperplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aldinger, K., Ben-Menachem, Y., Whalen, G.: Focal nodular hyperplasia of the liver associated with high-dosage estrogens. Arch. Intern. Med. 137, 357–359 (1977)PubMedGoogle Scholar
  2. 2.
    Alpert, E.: Human alpha-1 fetoprotein. In: Hepatocellular Carcinoma. Okuda, K. and Peters, R. L. (Eds.). New York: John Wiley and Sons, 1976a, pp. 353–367Google Scholar
  3. 3.
    Alpert, L. I.: Veno-occlusive disease of the liver associated with oral contraceptives. Hum. Pathol. 7, 709–718 (1976b)PubMedGoogle Scholar
  4. 4.
    Ameriks, J. A., Thompson, N. W., Frey, C. F., Appelman, H. D., Walter, J. F.: Hepatic cell adenomas, spontaneous liver rupture, and oral contraceptives. Arch. Surg. 110, 548–556 (1975)PubMedGoogle Scholar
  5. 5.
    Andersen, P. H., Packer, J. T.: Hepatic adenoma. Observations after estrogen withdrawal. Arch. Surg. 111, 898–900 (1976)PubMedGoogle Scholar
  6. 6.
    Anthony, P. P.: Hepatoma associated with androgenic steroids. Lancet 1, 685–686 (1975)PubMedGoogle Scholar
  7. 7.
    Antoniades, K., Campbell, W. N., Hecksher, R. H., Kessler, W. B., McCarthy, G. E., Jr.: Liver cell adenoma and oral contraceptives. Double tumor development. JAMA 234, 628–629 (1975)PubMedGoogle Scholar
  8. 8.
    Baek, S., Sloane, C. E., Futterman, S. C.: Benign liver cell adenoma associated with use of oral contraceptive agents. Ann. Surg. 183, 239–242 (1976)PubMedGoogle Scholar
  9. 9.
    Balázs, M.: Electron microscopic study of benign hepatoma in a patient on oral contraceptives. Beitr. Pathol. Bd. 159, 299–306 (1976)Google Scholar
  10. 10.
    Bartók, I., Garas, S., Szabó, L.: Oral contraceptives and benign liver tumour. Lancet 1, 478–479 (1976)Google Scholar
  11. 11.
    Baum, J. K.: Liver tumors and oral contraceptives. JAMA 232, 1329 (1975)PubMedGoogle Scholar
  12. 12.
    Baum, J. K., Holtz, F., Bookstein, J. J., Klein, E. W.: Possible association between benign hepatomas and oral contraceptives. Lancet 2, 926–929 (1973)PubMedGoogle Scholar
  13. 13.
    Beaconsfield, P.: Liver tumours and steroid hormones. Lancet 1, 516–517 (1974)Google Scholar
  14. 14.
    Begg, C. F., Berry, W. H.: Isolated nodules of regenerative hyperplasia of the liver. Am. J. Clin. Pathol. 27, 447–463 (1953)Google Scholar
  15. 15.
    Belavady, B., Krishnamurthi, D., Mohiuddin, S. M., Rao, P. U.: Metabolic effects of oral contraceptives in monkeys fed adequate protein and low protein diets. Indian J. Exp. Biol. 11, 15–22 (1973)PubMedGoogle Scholar
  16. 16.
    Benz, E. J., Baggenstoss, A. H.: Focal cirrhosis of the liver. Its relation to the so-called hamartoma (adenoma, benign hepatoma). Cancer 6, 743–755 (1953)PubMedGoogle Scholar
  17. 17.
    Berg, J. W., Ketelaar, R. J., Rose, E. F., Vernon, R. G.: Hepatomas and oral contraceptives. Lancet 2, 349–350 (1974)PubMedGoogle Scholar
  18. 18.
    Bernstein, M. S., Hunter, R. L., Yachnin, S.: Hepatoma and peliosis hepatis developing in a patient with Fanconi’s anemia. New Engl. J. Med. 284, 1135–1136 (1971)PubMedGoogle Scholar
  19. 19.
    Blendis, L. M., Parkinson, M. C., Shilkin, K. B., Williams, R.: Nodular regenerative hyperplasia of the liver in Felty’s syndrome. Q. J. Med. 169, 25–32 (1974)Google Scholar
  20. 20.
    Brander, W., Bewick, M., Ogg, C.: Liver hamartomas in patients on oral contraceptives. Br. Med. J. 2, 80 (1974)Google Scholar
  21. 21.
    Brander, W. L., Vosnides, G., Ogg, C. S., West, I. E.: Multiple hepatocellular tumours in a patient treated with oral contraceptives. Virchows Arch. 370, 69–76 (1976)Google Scholar
  22. 22.
    Bruguera, M.: Hepatoma associated with androgenic steroids. Lancet 1, 1295 (1975)Google Scholar
  23. 23.
    Catalano, P. W., Early, M. E., Topolosky, H. W., Martin, E. W., Jr., Carey, L. C.: Focal nodular hyperplasia of the liver. Report of six patients. Concepts of surgical management. Cancer 39, 587–591 (1977)PubMedGoogle Scholar
  24. 24.
    Cattan, D., Vesin, P., Wautier, J., Khalifat, R., Meignan, S.: Liver tumours and steroid hormones. Lancet 1, 878 (1974)PubMedGoogle Scholar
  25. 25.
    Christopherson, W. M., Collier, H. S.: Primary benign liver-cell tumors in infancy and childhood. Cancer 6, 853–861 (1953)PubMedGoogle Scholar
  26. 26.
    Christopherson, W. M., Mays, E. T.: Liver tumors and contraceptive steroids. Experience with one hundred registry patients. J. Natl. Cancer Inst. 58, 167–171 (1977)PubMedGoogle Scholar
  27. 27.
    Christopherson, W. M., Mays, E. T., Barrows, G. H.: Liver tumors in women on contraceptive steroids. Obstet. Gynecol. 48, 221–223 (1975)Google Scholar
  28. 28.
    Christopherson, W. M., Mays, E. T., Barrows, G.: A clinicopathologic study of steroid-related tumors. Am. J. Surg. Pathol. 1, 31–41 (1977)PubMedGoogle Scholar
  29. 29.
    Classen, M., Elster, K., Pesch, H. J., Demling, L.: Portal hypertension caused by partial nodular transformation of the liver. Gut 11, 245–249 (1970)PubMedGoogle Scholar
  30. 30.
    Connolly, C., O’Brien, M. J.: Nodular transformation of the liver. Hum. Path. 8, 350–352 (1977)PubMedGoogle Scholar
  31. 31.
    Contostavlos, D. L.: Benign hepatomas and oral contraceptives. Lancet 2, 1200 (1973)PubMedGoogle Scholar
  32. 32.
    Cornish, P. G.: Liver cell adenoma. JAMA 235, 249 (1976)PubMedGoogle Scholar
  33. 33.
    Davies, J. N. P.: Liver tumours and steroid hormones. Lancet 1, 516 (1974)Google Scholar
  34. 34.
    Davis, J. B., Schenken, K. R., Zimmerman, O.: Massive hemoperitoneum from rupture of benign hepatocellular adenoma. Surgery 73, 181–184 (1973)PubMedGoogle Scholar
  35. 35.
    Davis, M., Postmann, B., Searle, M., Wright, R., Williams, R.: Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br. Med. J. 2, 496–498 (1975)Google Scholar
  36. 36.
    Dick, A. P., Gresham, G. A.: Partial nodular transformation of the liver presenting with ascites. Gut 13, 289–292 (1972)PubMedGoogle Scholar
  37. 37.
    Editorial: Oral contraceptives and cancer. Lancet 2, 911 (1972)Google Scholar
  38. 38.
    Editorial: Liver tumours and steroid hormones. Lancet 2, 1481–1482 (1973)Google Scholar
  39. 39.
    Editorial: Liver tumours and the pill. Br. Med. J. 2, 3–4 (1974)Google Scholar
  40. 40.
    Editorial: Oral contraceptives and liver nodules. Lancet 1, 843 (1976)Google Scholar
  41. 41.
    Edmonds, A. M., Hennigar, G. R., Crooks, R.: Galactosemia. Pediatrics 10, 40–47 (1952)PubMedGoogle Scholar
  42. 42.
    Edmondson, H. A.: Tumors of the liver and Intrahepatic Bile Ducts. Atlas of Tumor Pathology, Sect. VII, Fasc. 25. Washington, D.C.: Armed Forces Inst. Pathol., 1958Google Scholar
  43. 43.
    Edmondson, H. A., Henderson, B. E., Benton, B.: Liver-cell adenomas associated with use of oral contraceptives. New Engl. J. Med. 294, 470–472 (1976)PubMedGoogle Scholar
  44. 44.
    Edmondson, H. A., Reynolds, T. B., Henderson, B. E., Benton, B.: Regression of liver cell adenomas associated with oral contraceptives. Ann. Intern. Med. 86, 180–182 (1977)PubMedGoogle Scholar
  45. 45.
    Everson, R. B., Fraumeni, J. F., Jr.: Familial glioblastoma with hepatic focal nodular hyperplasia. Cancer 38, 310–313 (1976)PubMedGoogle Scholar
  46. 46.
    Everson, R. B., Museles, M., Henson, D. E., Grundy, G. W.: Focal nodular hyperplasia of the liver in a child with hemihypertrophy. J. Pediatr. 88, 985–987 (1976)PubMedGoogle Scholar
  47. 47.
    Farber, E.: On the pathogenesis of experimental hepatocellular carcinoma. In: Hepatocellular Carcinoma. Okuda, K., Peters, R. L. (Eds.). New York: John Wiley and Sons, 1976, pp. 1–22Google Scholar
  48. 48.
    Farrell, G. C., Joshua, D. E., Uren, R. F., Baird, J. J., Perkins, K. W., Kronenberg, H.: Androgen-induced hepatoma. Lancet 1, 430–432 (1975)PubMedGoogle Scholar
  49. 49.
    Fechner, R. E.: Benign hepatic lesions and orally administered contraceptives. A report of seven cases and a critical analysis of the literature. Hum. Pathol. 8, 255–268 (1977)PubMedGoogle Scholar
  50. 50.
    Fechner, R. E., Roehm, J. O. F.: Angiographic and pathologic correlations of hepatic focal nodular hyperplasia. Am. J. Surg. Pathol. 1, 217–224 (1977)PubMedGoogle Scholar
  51. 51.
    Fisher, A. W. F., Curry, B., Jacques, J.: Solitary liver nodules. Can. Med. Assoc. J. 112, 1196–1200 (1975)PubMedGoogle Scholar
  52. 52.
    Galloway, S. J., Casarella, W. J., Lattes, R., Seaman, W. B.: Minimal deviation hepatoma. A new entity. Am. J. Roentgenol. 125, 184–192 (1975)Google Scholar
  53. 53.
    Glassberg, A. B., Rosenbaum, E. H.: Oral contraceptives and malignant hepatoma. Lancet 1, 479 (1976)PubMedGoogle Scholar
  54. 54.
    Goldfarb, S.: Sex hormones and hepatic neoplasia. Cancer Res. 36, 2584–2588 (1976)PubMedGoogle Scholar
  55. 55.
    Goldstein, H. M., Neiman, H. L., Mena, E., Bookstein, J. J., Appelman, H. D.: Angiographic findings in benign liver cell tumors. Radiology 110, 339–343 (1973)Google Scholar
  56. 56.
    Grabowski, M., Stenram, U., Bergqvist, A.: Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver. Acta Pathol. Microbiol. Scand. 83, 615–622 (1975)Google Scholar
  57. 57.
    Guy, J. T., Auslander, M. O.: Androgenic steroids and hepatocellular carcinoma. Lancet 1, 148 (1973)PubMedGoogle Scholar
  58. 58.
    Harris, M., Rash, R. M., Dymock, I. W.: Nodular non-cirrhotic liver associated with portal hypertension in a patient with rheumatoid arthritis. J. Clin. Pathol. 27, 963–966 (1974)PubMedGoogle Scholar
  59. 59.
    Havrilla, T. R., Pepe, R. G., Alfidi, R. J., Haaga, J. R.: Benign hepatic tumors and cysts in women using contraceptive agents. Cleveland Clin. Q. 44, 41–47 (1977)Google Scholar
  60. 60.
    Henderson, B. E., Benton, B., Edmondson, H. A.: Hepatocellular carcinoma and oral contraceptives. JAMA 236, 560 (1976)PubMedGoogle Scholar
  61. 61.
    Henderson, J. T., Richmond, J., Sumerling, M. D.: Androgenic-anabolic steroid therapy and hepatocellular carcinoma. Lancet 1, 934 (1973)PubMedGoogle Scholar
  62. 62.
    Henson, S. W., Gray, H. K., Dockerty, M. B.: Benign tumors of the liver. 1. Adenomas. Surg. Gynecol. Obstet. 103, 23–30 (1956)PubMedGoogle Scholar
  63. 63.
    Hermann, R. E., David, T. E.: Spontaneous rupture of the liver caused by hepatomas. Surgery 74, 715–719 (1973)PubMedGoogle Scholar
  64. 64.
    Holder, L. E., Gnarra, D. J., Lampkin, B. C., Nishiyama, H., Perkins, P.: Hepatoma associated with anabolic steroid therapy. Am. J. Roentgenol. 124, 638–642 (1975)Google Scholar
  65. 65.
    Horvath, E., Kovacs, K., Ross, S. C.: Benign hepatoma in a young woman on contraceptive steroids. Lancet 1, 357–358 (1974)PubMedGoogle Scholar
  66. 66.
    Howell, R. R., Stevenson, R. E., Ben-Menachem, Y., Phyliky, R. L., Berry, D. H.: Hepatic adenomata with type I glycogen storage disease. JAMA 236, 1481–1484 (1976)PubMedGoogle Scholar
  67. 67.
    Irey, N. S., Norris, H. J.: Intimai vascular lesions associated with female reproductive steroids. Arch. Pathol. 96, 227–234 (1973)PubMedGoogle Scholar
  68. 68.
    Irey, N. S., Manion, W. C., Taylor, H. B.: Vascular lesions in women taking oral contraceptives. Arch. Pathol. 89, 1–8 (1970)PubMedGoogle Scholar
  69. 69.
    Ishak, K. G.: Primary hepatic tumors in childhood. In: Progress in Liver Diseases. Popper, H., Schaffner, F. (Eds.). New York: Grune and Stratton, 1976, pp. 636–667Google Scholar
  70. 70.
    Ishak, K. G., Rabin, L.: Benign tumors of the liver. Med. Clin. North Am. 59, 995–1013 (1975)PubMedGoogle Scholar
  71. 71.
    Jhingran, A. K., Mukhopadhyay, A. K., Ajmani, S. K., Johnson, P.C.: Hepatic adenomas and focal nodular hyperplasia of the liver in young women on oral contraceptives. Case reports. J. Nucl. Med. 18, 263–266 (1977)PubMedGoogle Scholar
  72. 72.
    Johnson, F. L.: Androgenic-anabolic steroids and hepatocellular carcinoma. In: Hepatocellular Carcinoma. Okuda, K., Peters, R. L. (Eds.). New York: John Wiley and Sons, 1976, pp. 95–103Google Scholar
  73. 73.
    Johnson, F. L., Feagler, J. R., Lerner, K. G., Majerus, P. W., Siegel, M., Hartmann, J. R., Thomas, E. D.: Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 2, 1273–1276 (1972)PubMedGoogle Scholar
  74. 74.
    Kalra, T. M. S., Mangla, J. C., DePapp, E. W.: Benign hepatic tumors and oral contraceptive pills. Am. J. Med. 61, 871–877 (1976)PubMedGoogle Scholar
  75. 75.
    Kay, C. R.: Oral contraceptives and liver tumours. Lancet 2, 127 (1975)PubMedGoogle Scholar
  76. 76.
    Kay, S., Schatzki, P. F.: Ultrastructure of a benign liver cell adenoma. Cancer 28, 755–762 (1971)PubMedGoogle Scholar
  77. 77.
    Kelso, D. R.: Benign hepatomas and oral contraceptives. Lancet 1, 315–316 (1974)PubMedGoogle Scholar
  78. 78.
    Kew, M. C., Van Coller, B., Prowse, C. M., Skikne, B., Wolfsdorf, J. I., Isdale, J., Krawitz, S., Altman, H., Levin, S. E., Bothwell, T. H.: Occurrence of primary hepatocellular cancer and peliosis hepatis arter treatment with androgenic steroids. S. Afr. Med. J. 50, 1233–1237 (1976)PubMedGoogle Scholar
  79. 79.
    Klatskin, G.: Hepatic tumors. Possible relationship to use of oral contraceptives. Gastroenterology 73, 386–394 (1977)PubMedGoogle Scholar
  80. 80.
    Knapp, W. A., Ruebner, B. H.: Hepatomas and oral contraceptives. Lancet 1, 270–271 (1974)PubMedGoogle Scholar
  81. 81.
    Knowles, D. M., Wolff, M.: Focal nodular hyperplasia of the liver. A clinicopathologic study and review of the literature. Hum. Pathol. 7, 533–545 (1976)PubMedGoogle Scholar
  82. 82.
    Knowles, D. M., Kaye, G. I., Godman, G. C.: Nodular regenerative hyperplasia of the liver. Gastroenterology 69, 746–751 (1975)PubMedGoogle Scholar
  83. 83.
    Koka, M., Stejskal, R., Wagner, B., Rao, J. S., McDonnell, R. G.: Pathologic effects of Ovulen (R) and Enovid-E (R) on beagle dogs after 7 years of treatment. XI Intern. Congr., Intern. Acad. Pathol., October 17–23. Washington, D.C. (Abstract), 1976Google Scholar
  84. 84.
    Lansing, P. B., McQuitty, J. T., Bradburn, D. M.: Benign liver tumors: What is their relationship to oral contraceptives. Am. Surg. 42, 744–760 (1976)PubMedGoogle Scholar
  85. 85.
    Leevy, C. M., Popper, H., Sherlock, S.: Diseases of the Liver and Biliary Tract, Standardization of Nomenclature, Diagnostic Criteria, and Diagnostic Methodology. Fogarty International Center Proceedings No. 22. Washington, D.C.: U.S. Government Printing Office 1976, pp. 1–212Google Scholar
  86. 86.
    Lesna, M., Spencer, I., Wolker, W.: Liver nodules and androgens. Lancet 1, 1124 (1976)PubMedGoogle Scholar
  87. 87.
    Lingeman, C. H.: Evaluating carcinogenicity of oral contraceptives. JAMA 236, 1690 (1976)PubMedGoogle Scholar
  88. 88.
    Lurie, B., Novis, B., Bank, S., Silver, W., Botha, J. B. C., Marks, I. N.: CRST syndrome and nodular transformation of the liver. Gastroenterology 64, 457–461 (1973)PubMedGoogle Scholar
  89. 89.
    Maillard, J. N., Potet, F., Benhamou, J. P.: Transformation nodulaire partielle du foie avec hypertension portale. Presse Med. 75, 2799–2802 (1967)PubMedGoogle Scholar
  90. 90.
    Mahboubi, E., Shubik, P.: Benign liver cell adenomas in women using oral contraceptives. Cancer Lett. 1, 331–338 (1976)Google Scholar
  91. 91.
    Malt, R. A., Hershberg, R. A., Miller, W. L.: Experience with benign tumors of the liver. Surg. Gynecol. Obstet. 130, 285–291 (1970)PubMedGoogle Scholar
  92. 92.
    Mays, E. T.: Hepatocellular carcinoma and oral contraceptives. JAMA 236, 560 (1976)Google Scholar
  93. 93.
    Mays, E. T., Christopherson, W. H., Barrows, G. H.: Focal nodular hyperplasia of the liver. Possible relationship to oral contraceptives. Am. J. Clin. Pathol. 61, 735–746 (1974)PubMedGoogle Scholar
  94. 94.
    Mays, E. T., Christopherson, W. M., Mahr, M. M., Williams, H. C.: Hepatic changes in young women ingesting contraceptive steroids: hepatic hemorrhage and primary hepatic tumors. JAMA 235, 730–732 (1976)PubMedGoogle Scholar
  95. 95.
    McAvoy, J. M., Tompkins, R. K., Longmire, W. P., Jr.: Benign hepatic tumors and their association with oral contraceptives. Arch. Surg. 111, 761–767 (1976)PubMedGoogle Scholar
  96. 96.
    McKinney, G. R., Weikel, J. H., Jr., Webb, W. K., Dick, R. G.: Use of the life-table technique to estimate effects of certain steroids on probability of tumor formation in a long-term study in rats. Toxicol. Appl. Pharmacol. 12, 68–79 (1968)PubMedGoogle Scholar
  97. 97.
    McLoughlin, M. J., Gilday, D. L.: Angiography and colloid scanning of benign mass lesions of the liver. Clin. Radiol. 23, 377–391 (1973)Google Scholar
  98. 98.
    McLoughlin, M. J., Colapinto, R. F., Gilday, D. L., Hobbs, B. B., Korobkin, M. T., McDonald, P., Phillips, M. J.: Focal nodular hyperplasia of the liver. Angiography and radioisotope scanning. Radiology 107, 257–263 (1973)PubMedGoogle Scholar
  99. 99.
    Meadows, A. T., Naiman, J. L., Valdes-Dapena, M.: Hepatoma associated with androgen therapy for aplastic anemia. J. Pediatr. 84, 108–110 (1974)Google Scholar
  100. 100.
    Meyer, P., Livolsi, V. A., Cornog, J. L.: Hepatoblastoma associated with an oral contraceptive. Lancet 2, 1387 (1974)PubMedGoogle Scholar
  101. 101.
    Minow, R. A., Tompkins, R. K., Gitnick, G. L.: Diarrhea syndrome in hepatic adenoma. Am. J. Dig. Dis. 20, 182–186 (1975)PubMedGoogle Scholar
  102. 102.
    Model, D. G., Fox, J. A., Jones, R. W.: Multiple hepatic adenomas associated with an oral contraceptive. Lancet 1, 865 (1975)Google Scholar
  103. 103.
    Mokrohisky, S. T., Ambruso, D. R., Hathaway, W. E.: Fulminant hepatic neoplasia after androgen therapy. New Engl. J. Med. 296, 1411–1412 (1977)PubMedGoogle Scholar
  104. 104.
    Morley, J. E., Myers, J. B., Sack, F. S., Kalk, F., Epstein, E. E., Lannon, J.: Enlargement of cavernous haemangioma associated with exogenous administration of oestrogens. S. Afr. Med. J. 1, 695–697 (1974)Google Scholar
  105. 105.
    Morton, R. F., Hebel, J. R.: Liver-cell adenomas and oral contraceptives. New Engl. J. Med. 295, 52 (1976)Google Scholar
  106. 106.
    Motsay, G. J., Gamble, W. G.: Clinical experience with hepatic adenomas. Surg. Gynecol. Obstet. 134, 415–418 (1972)PubMedGoogle Scholar
  107. 107.
    Mowat, A. P., Gutjahr, P., Portmann, B., Dawson, J. L., Williams, R.: Focal nodular hyperplasia of the liver. A rational approach to treatment. Gut 17, 492–494 (1976)PubMedGoogle Scholar
  108. 108.
    Mulvihill, J. J., Ridolfi, R. L., Schultz, F. R., Borzy, M. S., Haughton, P. B. T.: Hepatic adenoma in Fanconi anemia treated with oxymetholone. J. Pediatr. 87, 122–124 (1975)PubMedGoogle Scholar
  109. 109.
    Nadell, J., Kosek, J.: Peliosis hepatis. Twelve cases associated with oral androgen therapy. Arch. Pathol. Lab. Med. 101, 405–410 (1977)PubMedGoogle Scholar
  110. 110.
    Nikaidoh, H., Boggs, J., Swenson, O.: Liver tumors in infants and children. Clinical and pathological analysis of 22 cases. Arch. Surg. 101, 245–257 (1970)Google Scholar
  111. 111.
    Nissen, E. D., Kent, D. R.: Liver tumors and oral contraceptives. Obstet. Gynecol. 46, 460–467 (1975)PubMedGoogle Scholar
  112. 112.
    Oral Contraceptives and Health. An Interim Report from the Oral Contraception Study of the Royal College of General Practitioners. New York: Pitman Publishing Corporation, 1974, pp. 1–100Google Scholar
  113. 113.
    Osterholzer, H. O., Grillo, D., Kruger, P. S., Dunnihoo, D. R.: The effect of oral contraceptive steroids on branches of the uterine artery. Obstet. Gynecol. 49, 227–232 (1977)PubMedGoogle Scholar
  114. 114.
    O’Sullivan, J. P.: Oral contraceptives and liver tumours. Proc. R. Soc. Med. 69, 351–353 (1976)PubMedGoogle Scholar
  115. 115.
    O’Sullivan, J. P., Rosswick, R. P.: Oral contraceptives and malignant hepatic tumors. Lancet 1, 1124–1125 (1976)PubMedGoogle Scholar
  116. 116.
    O’Sullivan, J. P., Wilding, R. P.: Liver hamartomas in patients on oral contraceptives. Br. Med. J. 2, 7–10 (1974)Google Scholar
  117. 117.
    Phillips, M. J., Langer, B., Stone, R., Fisher, M. M., Ritchie, S.: Benign liver cell tumors. Classification and ultrastructural pathology. Cancer 32, 463–470 (1973)PubMedGoogle Scholar
  118. 118.
    Pollice, L.: Primary hepatic tumors in infancy and childhood. Am. J. Clin. Pathol. 60, 512–521 (1973)PubMedGoogle Scholar
  119. 119.
    Port, R. B., Patasnick, J. P., Ranniger, K.: Angiographic demonstration of hepatoma in association with Fanconi’s anemia. Am. J. Roentgenol. 113, 82–83 (1971)Google Scholar
  120. 120.
    Pryor, A. G., Cohen, R. J., Goldman, R. L.: Hepatocellular carcinoma in a woman on long-term oral contraceptives. Cancer 40, 884–888 (1977)PubMedGoogle Scholar
  121. 121.
    Recant, L., Lacey, P.: Fanconi’s anemia and hepatic cirrhosis. Clinicopathologic conference. Am. J. Med. 39, 464–475 (1965)Google Scholar
  122. 122.
    Reisman, T., Levi, J. U., Zeppa, R., Clark, R., Morton, R., Schiff, E. R.: Noncirrhotic portal hypertension in Felty’s syndrome. Am. J. Dig. Dis. 22, 145–148 (1977)PubMedGoogle Scholar
  123. 123.
    Rinehart, W., Felt, J. C.: Debate on oral contraceptives and neoplasia continues; answers remain elusive. Population Reports, Series A, Number 4, 69–104 (1977)Google Scholar
  124. 124.
    Rinehart, W., Ravenholt, R. T.: U.S. Morbidity and mortality trends relative to oral contraceptive use, 1955–1975, and Danish morbidity trends, 1953–1972. Population Reports, Series A, Number 4, 105–142 (1977)Google Scholar
  125. 125.
    Rooks, J. B., Ory, H. W., Ishak, K. G., Strauss, L. T., Greenspan, J. R., Tyler, C. W.: Association of hepatocellular adenoma and oral contraception. A case controlled study (In preparation)Google Scholar
  126. 126.
    Ross, D., Pina, J., Mirza, M., Galvan, A., Ponce, L.: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives. Ann. Intern. Med. 85, 203–204 (1976)PubMedGoogle Scholar
  127. 127.
    Sale, G. E., Lerner, K. G.: Multiple tumors after androgen therapy. Arch. Pathol. Lab. Med. 101, 600–603 (1977)PubMedGoogle Scholar
  128. 128.
    Sarna, G., Tomasulo, P., Lotz, M. J., Bubinak, J. F., Shulman, N. R.: Multiple neoplasms in two siblings with a variant form of Fanconi’s anemia. Cancer 36, 1029–1033 (1975)PubMedGoogle Scholar
  129. 129.
    Schardein, J. L., Kaump, D. H., Woosley, E. T., Jellema, M. M.: Long-term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats. Toxicol. Appl. Pharmacol. 16, 10–23 (1970)PubMedGoogle Scholar
  130. 130.
    Sherlock, S., Feldman, C. A., Moran, B., Scheuer, P. J.: Partial nodular transformation of the liver with portal hypertension. Am. J. Med. 40, 195–203 (1966)PubMedGoogle Scholar
  131. 131.
    Sorenson, T. I. A., Baden, H.: Benign hepatocellular tumours. Scand. J. Gastroenterol. 10, 113–119 (1975)Google Scholar
  132. 132.
    Squire, R. A., Levitt, M. H.: Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res. 35, 3214–3223 (1975)PubMedGoogle Scholar
  133. 133.
    Stauffer, J. Q., Hill, R. B.: Systemic contraceptives and liver tumors. Ann. Intern. Med. 85, 122–123 (1976)PubMedGoogle Scholar
  134. 134.
    Stauffer, J. Q., Lapinski, M. W., Honold, D. J., Myers, J. K.: Focal nodular hyperplasia of the liver and intrahepatic hemorrhage in young women on oral contraceptives. Ann. Intern. Med. 83, 301–306 (1975)PubMedGoogle Scholar
  135. 135.
    Steiner, P. E.: Nodular regenerative hyperplasia of the liver. Am. J. Pathol. 35, 943–953 (1959)PubMedGoogle Scholar
  136. 136.
    Steinherz, P. B., Canale, V. C., Miller, D. R.: Hepatocellular carcinoma, transfusion-induced hemochromatosis and congenital hypoplastic anemia (Blackfan-Diamond syndrome). Am. J. Med. 60, 1032–1035 (1976)PubMedGoogle Scholar
  137. 137.
    Stenwig, A. E., Solgaard, T.: Recurrent benign hepatoma associated with an oral contraceptive. A case report. Virchows Arch. 367, 337–343 (1975)Google Scholar
  138. 138.
    Sweeney, E. C. and Evans, D. J.: Liver lesions and androgenic steroid therapy. Lancet 2, 1042 (1975)PubMedGoogle Scholar
  139. 139.
    Sweeney, E. C., Evans, D. J.: Hepatic lesions in patients treated with synthetic anabolic steroids. J. Clin. Pathol. 29, 626–633 (1976)PubMedGoogle Scholar
  140. 140.
    Teng, C. T., Daeschner, C. W., Jr., Singleton, E. B., Rosenberg, H. S., Cole, V. S., Hills, L. L., Brennan, J. C.: Liver disease and osteoporosis in children. I. Clinical observations. J. Pediatr. 59, 684–702 (1961)PubMedGoogle Scholar
  141. 141.
    Thalassinos, N. C., Lymberatos, C., Hadjioannou, J., Gardikas, C.: Liver-cell carcinoma after long-term oestrogen-like drugs. Lancet 1, 270 (1974)PubMedGoogle Scholar
  142. 142.
    Thomas, P. A., McCusker, J. J., Merrigan, E. H., Conte, N. F.: Lobar cirrhosis with nodular hyperplasia (hamartoma) of the liver treated by left hepatic lobectomy. Am. J. Surg. 112, 831–834 (1966)PubMedGoogle Scholar
  143. 143.
    Thorkild, I. A., Sorensen, A., Almersjo, O.: Focal nodular hyperplasia of the liver. Five cases. Scand. J. Gastroenterol. 11, 97–101 (1976)Google Scholar
  144. 144.
    Tigano, F., Ferlazzo, B., Barrile, A.: Oral contraceptives and malignant hepatoma. Lancet 2, 196 (1976)PubMedGoogle Scholar
  145. 145.
    Tountas, C., Paraskevas, G., Deligeorgi, H.: Benign hepatoma and oral contraceptives. Lancet 1, 1351–1352 (1974)PubMedGoogle Scholar
  146. 146.
    Tsou, K. C., Ledis, S., McCoy, M. G.: 5′ nucleotide phosphodiesterase isoenzyme pattern in the serum of human hepatoma. Cancer Res. 33, 2215–2217 (1973)PubMedGoogle Scholar
  147. 147.
    Tyrer, L. B.: Liver-cell adenomas and oral contraceptives. New Engl. J. Med. 295, 51–52 (1976)Google Scholar
  148. 148.
    Uszler, J. M., Swanson, L. A.: Focal nodular hyperplasia of the liver. Case report. J. Nucl. Med. 16, 831–832 (1975)PubMedGoogle Scholar
  149. 149.
    Vessey, M. P., Kay, C. R., Baldwin, J. A., Clarke, J. A., MacLeod, J. B.: Oral contraceptives and benign liver tumours. Br. Med. J. 1, 1064–1065 (1977)PubMedGoogle Scholar
  150. 150.
    Wazeter, F. X., Geil, R. G., Cookson, K. M., Berliner, V. R., Lamar, J. K.: Seven-year progress report on long-term oral contraceptive studies in female dogs and monkeys (Abstract). Toxicol. Appl. Pharmacol. 37, 178 (1976)Google Scholar
  151. 151.
    Whelan, T. J., Baugh, J. H., Chandor, S.: Focal nodular hyperplasia of the liver. Ann. Surg. 177, 150–158 (1973)PubMedGoogle Scholar
  152. 152.
    Wilens, G.: Adenoma of the liver. Am. J. Dis. Child. 55, 792–797 (1928)Google Scholar
  153. 153.
    Winckler, K., Poulsen, H.: Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand. J. Gastroenterol. 10, 699–704 (1975)Google Scholar
  154. 154.
    World Health Organzation. Report of the Meeting of Investigators on the Histological Classification of Tumors of the Liver, Biliary Tract and Pancreas. Switzerland, Nov. 24–28, 1975, pp. 1–22, GenevaGoogle Scholar
  155. 155.
    Ziegenfuss, J., Carabasi, R.: Androgens and hepatocellular carcinoma. Lancet 1, 262 (1973)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1979

Authors and Affiliations

  • Kamal G. Ishak

There are no affiliations available

Personalised recommendations